Clinical Trials List
2025-09-01 - 2029-12-31
Recruiting5
ICD-10M35.00
Sicca syndrome, unspecified
ICD-10M35.01
Sicca syndrome with keratoconjunctivitis
ICD-10M35.09
Sicca syndrome with other organ involvement
ICD-9710.2
Sicca syndrome
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Yi-Hsing Chen Division of Rheumatology
- 廖育婉 Division of Rheumatology
- Yi-Ming Chen Division of Rheumatology
- WEN-NAN HUANG Division of Rheumatology
- 顏在弘 Division of Rheumatology
- 高宗楙 Division of Rheumatology
- 陳彥如 Division of Rheumatology
- 謝祖怡 Division of Rheumatology
- 林靖才 Division of Rheumatology
- 謝佳偉 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tzn-Min Lin Division of Rheumatology
- 李向嚴 Division of Rheumatology
- 張克宇 Division of Rheumatology
- 林科宏 Division of Rheumatology
- 林韋睿 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張哲慈 Division of Rheumatology
- Shue-Fen Lo Division of Rheumatology
- Ping-Han Tsai Division of Rheumatology
- 陳彥輔 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張詩欣 風濕免疫科
- Po-Hao Huang 風濕免疫科
- 黃建中 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jeng-Hsien Yen 風濕免疫科
- 歐燦騰 風濕免疫科
- Chia-Chun Tseng 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
21 participants
-
Global
844 participants
